The blood mSEPT9 is capable of assessing the surgical therapeutic effect and the prognosis of colorectal cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The blood mSEPT9 is capable of assessing the surgical therapeutic effect and the prognosis of colorectal cancer
Authors
Keywords
-
Journal
Biomarkers in Medicine
Volume 12, Issue 9, Pages 961-973
Publisher
Future Medicine Ltd
Online
2018-07-25
DOI
10.2217/bmm-2018-0012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location
- (2017) Lele Song et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening
- (2017) Lele Song et al. Epigenomics
- The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis
- (2017) Lele Song et al. Scientific Reports
- Localized Colon Cancer, Version 3.2013
- (2017) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- Detection of Colorectal Cancer Using a Simplified SEPT9 Gene Methylation Assay Is a Reliable Method for Opportunistic Screening
- (2016) Dong Wu et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests
- (2016) Le-Le Song et al. World Journal of Gastrointestinal Oncology
- Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel
- (2016) Kei A. Sato et al. PLoS One
- Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer
- (2016) Jiaolin Zhou et al. PLoS One
- Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
- (2015) Thomas Reinert et al. GUT
- Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker
- (2015) Gloria Ravegnini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm
- (2015) Peng Jin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Accuracy of Fecal Immunochemical Tests for Colorectal Cancer
- (2014) Jeffrey K. Lee et al. ANNALS OF INTERNAL MEDICINE
- Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future
- (2014) Yuemin Li et al. Biomarkers in Medicine
- Postoperative serum methylation levels ofTAC1andSEPT9are independent predictors of recurrence and survival of patients with colorectal cancer
- (2014) CheeKian Tham et al. CANCER
- Validation of a Real-Time PCR-Based Qualitative Assay for the Detection of Methylated SEPT9 DNA in Human Plasma
- (2014) N. T. Potter et al. CLINICAL CHEMISTRY
- Multitarget Stool DNA Testing for Colorectal-Cancer Screening
- (2014) Thomas F. Imperiale et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating Methylated Septin 9 Nucleic Acid in the Plasma of Patients with Gastrointestinal Cancer in the Stomach and Colon
- (2014) Hye Seung Lee et al. Translational Oncology
- Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer
- (2014) WENHUA XIAO et al. Oncology Letters
- Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer
- (2013) Timothy Robert Church et al. GUT
- DNA Methylation of the Homeobox Genes PITX2 and SHOX2 Predicts Outcome in Non–small-cell Lung Cancer Patients
- (2012) Dimo Dietrich et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers
- (2012) Kinga Tóth et al. PLoS One
- Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
- (2011) Jorja D Warren et al. BMC Medicine
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started